The Lundquist Institute Launches the Nation’s First Adult Exercise Medicine Fellowship
New physician fellowship, leadership of the Academy of Exercise Medicine, and groundbreaking…
Dyne Therapeutics Announces Pricing of Upsized $375 Million Public Offering of Common Stock
July 21, 2026 22:46 ET | Source: Dyne Therapeutics, Inc. WALTHAM, Mass.,…
GlycoReset Supplement Facts Released: Consumer Safety Report Details New Analysis About Glyco Reset Ingredients & Side Effects Risk
Wilmington, DE, July 21, 2026 (GLOBE NEWSWIRE) -- These statements have not…
Picard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing Compliance
July 21, 2026 20:48 ET | Source: Picard Medical, Inc. -Reverse stock…
Enterome Phase 2 data show EO2463-induced CD8 T-cell expansion correlates with progression-free survival in patients with indolent non-Hodgkin lymphoma in the watch-and-wait setting
PRESS RELEASE Magnitude of EO2463-induced CD8 T-cell expansion during monotherapy statistically significantly…
OMEICOS OMT-28 Headed for Phase 3 in Primary Mitochondrial Diseases (PMD) Following Positive End-of-Phase 2 Meeting with the FDA
Feedback from the U.S. Food and Drug Administration (FDA) supports acceleration of…
Carbios reaches milestone of 100 batches at its Industrial demonstration plant and expands its licensing offering to the textile market
Validation of the "Fiber-to-Fiber" biorecycling process under conditions representative of industrial operations100th…
VERAXA Biotech Announces Regulatory Progress with its BiTAC-TCE Development Plan
ZURICH, SWITZERLAND – July 20, 2026 – VERAXA Biotech AG (NASDAQ: VRXA;…
Harrow Highlights Growing Clinical Evidence Supporting IHEEZO and BYOOVIZ at ASRS 2026 Annual Meeting
July 20, 2026 07:00 ET | Source: Harrow, Inc. NASHVILLE, Tenn., July…
